Implementation of an INR self-testing and self-management programme in common ambulatory private practice: Our experience with 90 patients

Swiss Medical Weekly

Volumn 141, Issue MAY, 2011, Pages

  Reverdin, Stephane ^a   Schnetzler, Bruno ^a   Gagneux, Geraldine ^b   Gavignet, Caroline ^b   Boehlen, Françoise ^a   De Moerloose, Philippe ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Education; INR; Oral anticoagulation; Self management; Vitamin K antagonists

Indexed keywords

AMBULATORY CARE; ANTICOAGULATION; ARTICLE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT AUTONOMY; PATIENT SATISFACTION; PRIVATE PRACTICE; QUESTIONNAIRE; SAFETY; SELF MANAGEMENT PROGRAMME; SELF TESTING PROGRAMME; SWITZERLAND; TEACHING; ADULT; AGED; DRUG ANTAGONISM; DRUG MONITORING; FEMALE; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; SELF CARE; SELF EVALUATION;

ANTICOAGULANT AGENT; VITAMIN K GROUP;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; DIAGNOSTIC SELF EVALUATION; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; SELF CARE; VITAMIN K;

EID: 79958208185     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13199     Document Type: Article

References (22)

1. Filippi A, Sessa E, Trifiro G, Mazzaglia G, Pecchioli S, Caputi AP, et al. Oral anticoagulant therapy in Italy: prescribing prevalence and clinical reasons. Pharmacol Res. 2004;50(6):601-3. (Pubitemid 39388970)
2. Nilsson GH, Bjorholt I, Johnsson H. Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population. BMC Fam Pract. 2003;4:3.
3. Holm T, Lassen JF. How many patients are on oral anticoagulant therapy in Denmark? Methods to estimate the number. Ugeskr Laeger. 2003;165(18):1871-5. (Pubitemid 38094625)
4. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991;324(26):1865-75.
5. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1998;114(5Suppl):445S-69S. (Pubitemid 28535775)
6. Kapiotis S, Quehenberger P, Speiser W. Evaluation of the new method Coaguchek for the determination of prothrombin time from capillary blood: comparison with Thrombotest on KC-1. Thromb Res. 1995;77(6):563-7.
7. Machin SJ, Mackie IJ, Chitolie A, Lawrie AS. Near patient testing (NPT) in haemostasis - a synoptic review. Clin Lab Haematol. 1996;18(2):69-74. (Pubitemid 26291806)
8. Bereznicki LR, Jackson SL, Peterson GM, Jeffrey EC, Marsden KA, Jupe DM. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol. 2007;60(3):311-4. (Pubitemid 46447750)
9. Hentrich DP, Fritschi J, Müller PR, Wuillemin WA. INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation. Thrombosis research. 2007;119(4):489-95. (Pubitemid 46157254)
10. Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000;356(9224):97-102. (Pubitemid 30438510)
11. Menendez-Jandula B, Souto JC, Oliver A, Montserrat I, Quintana M, Gich I, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med. 2005;142(1):1-10.
12. Christensen TD, Maegaard M, Sorensen HT, Hjortdal VE, Hasenkam JM. Self-management versus conventional management of oral anti-coagulant therapy: A randomized, controlled trial. Eur J Intern Med. 2006;17(4):260-6. (Pubitemid 43817515)
13. Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608-20.
14. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367(9508):404-11. (Pubitemid 43184260)
15. Fritschi J, Raddatz-Muller P, Schmid P, Wuillemin WA. Patient self-management of long-term oral anticoagulation in Switzerland. Swiss Med Wkly. 2007;137(17-18):252-8. (Pubitemid 46918008)
16. Fitzmaurice DA, Machin SJ. Recommendations for patients undertaking self management of oral anticoagulation. Bmj. 2001;323(7319):985-9. (Pubitemid 33016049)
17. Ansell J, Jacobson A, Levy J, Voller H, Hasenkam JM. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol. 2005;99(1):37-45. (Pubitemid 40261022)
18. Sobieraj-Teague M, Daniel D, Farrelly B, Coghlan D, Gallus A. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting. Thrombosis research. 2009;123(6):909-13.
19. Matchar DB JA, Dolor R, Edson R, Uyeda L, Phibbs CS, Vertrees JE, Shih MC, Holodniy M, Lavori P; THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608-20.
20. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-51.
21. Garcia D, Libby E, Crowther MA. The new oral anticoagulants. Blood. Oct 30.
22. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J. 2010;159(3):340-7 e1.